A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, 2-period, Crossover, Sleep Laboratory Study to Assess the Effect of Seltorexant Compared to Placebo on Respiration During Sleep in Adult Patients With Obstructive Sleep Apnea
Latest Information Update: 13 Jun 2022
At a glance
- Drugs Seltorexant (Primary)
- Indications Sleep apnoea syndrome
- Focus Therapeutic Use
- Sponsors Janssen Research & Development
Most Recent Events
- 01 Jul 2019 Status changed from recruiting to completed.
- 14 Jan 2019 New trial record
- 11 Jan 2019 Status changed from not yet recruiting to recruiting.